AEON Biopharma
AEON
AEON
15 hedge funds and large institutions have $29.3M invested in AEON Biopharma in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
15
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$19.8M | |
| 2 | +$3.4M | |
| 3 | +$1.44M | |
| 4 |
BlackRock
New York
|
+$1.35M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.08M |
Top Sellers
| 1 | -$2.49M | |
| 2 | -$2M | |
| 3 | -$1.58M | |
| 4 |
ECP
Empyrean Capital Partners
Los Angeles,
California
|
-$1.42M |
| 5 |
TCM
Tenor Capital Management
New York
|
-$1.42M |